Introduction 32
Treatment of poisoning from the consumption of ethanol and the management of 33 the intoxicated patient represents a significant burden on many health services. 34 Further, poisoning from the consumption of other alcohols notably methanol and 35 ethylene glycol occurs sporadically and from time-to-time outbreaks occur where 36 food, drink or medicines are contaminated, resulting in significant mortality [1] . The 37 essence of diagnosis is speed, and even in well-resourced health-care settings the 38 collection of blood samples for remote analysis may introduce delays that prevent 39 effective treatment. In communities and regions without recourse to gold-standard 40 pathology services, or in cases where the numbers of patients runs into the 41 hundreds [2] clinical teams may be forced to treat their patients symptomatically 42 without recourse to reliable diagnosis. Other complications arise when intoxication 43 from sedatives, such as γ-hydroxylbutyric acid (GHB) taken intentionally or through 44 malicious administration, is mistaken for ethanol abuse, or more seriously is 45 masked by ethanol consumption. Consequently it would appear there is a need, 46 across all scales of health services, for faster point-of-care toxicity screening for 47 methanol, ethanol, ethylene-glycol and 1,3-propandiol. It would also be helpful to be 48 able to screen simultaneously for the presence of sedatives such GHB, and more 49 recently, γ-butyrolactone. 50
Ethylene glycol and 1,3-propandiol are highly soluble in aqueous media with Henry's 51 Law constants of 4x10 6 mol.kg -1 .bar -1 and 910,000 mol.kg -1 .bar -1 respectively 52 making headspace analysis and, by implication, exhaled breath analysis unlikely to 53 be practicable; note that in comparison the Henry's Law constants for methanol and 54 ethanol are 230 mol.kg -1 .bar -1 and 190 mol.kg -1 .bar -1 respectively. 55
The utility of using saliva analysis for profiling methanol intoxication was proposed 56 in 2009 [3] and subsequently an active membrane [4 and 5] was used to recover 57 and analyse methanol and ethanol from human saliva with determination by 58 thermal desorption gas chromatography differential mobility spectrometry (TD-GC-59 DMS) across the concentration range 30 mg.dm -3 to 500 mg.dm -3 [6] . At that time 60 the possible utility of extending the approach to glycols was noted. In saliva fluids, 61 drugs of abuse have been reported to be detectable for between 5 and 48 hr in the 62 ng.cm -3 range [7] supporting the proposition of the development of saliva based 63 screens. Indeed, methanol and ethanol present in saliva samples has been previously determined by GC-FID, with the proposition for extending the approach 65 from confirmatory analyses to routine application in toxicology laboratories [8] . 66   This research focussed on methanol, ethanol, ethylene glycol, 1,3-propandiol and  67 GHB. Ethanol toxicity is dependent on individual tolerance and use, although levels 68 greater than 3 g.dm -3 to 4 g.dm -3 may be fatal due to respiratory depression and 69 blood ethanol concentrations between 500 mg.dm -3 and 700 mg.dm -3 may be 70 considered to be the highest that may be tolerated without neurological effects [9] . 71
Methanol, may cause metabolic acidosis, neurologic injuries, and death when 72 ingested and blood-serum methanol levels greater than 200 mg.dm -3 correlate with 73 ocular injury, while the minimal lethal dose of methanol in adults is believed to be 74 340 mg kg -1 of body weight [10] . Ethylene glycol is moderately toxic and its toxic by-75 products first affect the central nervous system, then the heart, and finally the 76 kidneys. Current recommendations are that treatment with Fomepizole is initiated 77 immediately if serum concentrations of methanol or ethylene glycol exceed 200 78 mg.dm -3 . In contrast ingestion of 1,3-propandiol is not as serious and large 79 quantities are required to cause perceptible health damage in humans with blood-80 plasma concentrations over 4 g.dm -3 associated with serious harm [11] . GHB has 81 useful therapeutic uses such as treating narcolepsy, however it is also a drug of 82 abuse and is associated with assault. The therapeutic range is narrow and 83 accidental overdosing is a common cause of injury with potentially fatal outcomes, 84 normally associated with cardiorespiratory arrest [12] . 85
The current work sought to extend the earlier TD-GC-DMS study to include a semi-86 quantitative diagnostic screen of alcohol toxicants and GHB based on a non-87 invasive saliva sampling methodology and establish if direct extraction from saliva 88 to a polydimethylsilicone coupon [13] with recovery and analysis by TD-GC-DMS was 89 feasible. The DMS platform was chosen as this technique has been demonstrated 90 to be effective for the rapid, robust and sensitive detection and quantitation of 91 alcohols in low resource settings [14] . 92
Experimental 93
Ethics, participant preparation and saliva sampling. 94
It is helpful to note at the outset that the volunteers who participated in this 95 research were not exposed to any chemical hazard(s). The study was conducted in 96 accordance with the ethical principles of Good Clinical Practice and the Declaration 97 of Helsinki. The local ethics committee (Ethical Advisory Committee, Loughborough 98 University, Loughborough, LE11 2DT) approved the studies (References G10-P23 99 and G10-P24) Three healthy adult male non-smokers volunteered to participate in 100 this study and gave written informed consent. The participants were recruited from 101 Loughborough University staff, students and their social networks. Each participant 102 provided two samples throughout the experimental campaign. 103
On the morning of their study visit the participant were asked not to: brush their 104 teeth; use any personal care products, or eat breakfast. Participants were also 105 asked to only drink cold water, and refrain from flavoured, caffeinated, or drinks 106 containing fruit juice(s). All saliva samples were taken in an in-vivo sample station 107 located in a small internal room, where privacy was ensured, at the Centre for 108
Analytical Science at the Chemistry Department of Loughborough University. A 109 chaperone, of the same gender as the participant, was present during sample 110 collection and access was restricted to only those researchers and participants 111 involved in the sampling process. After an introduction to the study the participants 112 were familiarised with the passive drool approach that was used to obtain a sample 113 of their saliva [13] , before proceeding to provide approximately 10 cm 3 of saliva. 114
The participants sat with their head tilted forward to cause saliva to pool at the front 115 of their mouth and then drain from their lips into a glass collection vial. On 116 completion of sampling the vial was sealed promptly with a Teflon TM faced screw-top 117 cap. Immediately after sampling the saliva was transferred to the laboratory where 118 1.8 cm 3 aliquots of the saliva sample was pipetted into 2 cm 3 chromatography 119 vials, which were sealed immediately with a screw cap fitted with a silicone septum. 120
These saliva aliquots were used immediately, within 3 hr of collection and 121 maintained at ambient temperature (20°C ± 2 o C) until disposal. Saliva residues 122 were disposed immediately after use by diluting with a disinfectant solution and 123 rinsed down a sink with a copious flow of running water. No cells or DNA were 124 retained or stored. 125
Chemicals 126
Ethanol, methanol, ethylene glycol, 1,3-propandiol , sodium chloride (purity of these 127 compounds ≥99.8%) and butanoic acid, 4-hydroxy-, ammonium salt (GHB) in 128 methanol (1 mg.cm -3 ) were obtained from Sigma Aldrich; see Table 1 . He carrier gas 129 was obtained from BOC, UK, and purified by passing through two triple-bed gas 130 purifiers mounted in series (Thames Restek). Nitrogen was generated on site (PEAK 131 Scientific, UK, model nk-10L-HP) and purified by passing through a charcoal 132 adsorbent-bed gas-purifier (Varian), a moisture filter (Varian), and a triple-bed gas 133 purifier (Thames Restek), all mounted in series. Water (>18MΩ) was generated on 134 site. 135
PDMS saliva sampler. 136
A titanium cylinder (6 mm long, 2 mm o.d. C-SPTD5-6MM Markes International Ltd) 137 coated on the internal and external surfaces with polydimethylsiloxane (internal wall 138 thickness 1 µm and external wall thickness 0.5 mm). was used to recover VOCs 139 from the saliva. This approach has been described previously for the in-vivo 140 sampling of Saliva VOCs [13] . The saliva sampler was prepared by cleaning with 141
Milton® sterilising liquid (Suffolk, UK) and then rinsing with deionised water before 142 conditioning under vacuum at 190°C for 15 hr. Once conditioned the PDMS rods 143 were inserted into a cleaned and conditioned glass thermal desorption tube and 144 thermally desorbed for 10 min at 190 °C; the resultant GC-MS trace provided 145 verification that the PDMS sampling media was free of contamination. On removal 146 from the thermal desorption unit the thermal desorption tube containing the PDMS 147 coated titanium cylinder was immediately capped, sealed and stored at 4 °C. 148
Before use the saliva-samplers were thermally desorbed again under the conditions 149
in Table 3 to remove any traces of possible VOC contamination that may have 150 occurred during storage and to provide further verification that the sampler was free 151 of contamination. 152
Instrumentation 153
Two instrument configurations were used in this study. Method development and 154 calibration were undertaken using liquid injections to a GC-DMS. Characterisation of 155 the recovery of the analytes from spiked saliva samples was undertaken using a 156 thermal desorption unit interfaced to the GC-MS ( Figure 1) . 157
Multi-linear regression was used to optimise the differential mobility spectrometer 158 operating parameters of: dispersion-field; temperature; number of compensation-159 field steps; and compensation-field step duration (DOE PRO XL Software for 160 Microsoft Excel, SigmaZone). Data were generated from a central composite design 161 (CCD) with each of the 4 factors at 4 levels with replicates at five different 162 concentrations, see Table 2 [15] . The DMS parameters were optimised for 163 maximum sensitivity while maintaining "satisfactory" resolution between the ion 164 clusters generated within the 63 Ni ionisation source see Table 3, and Figures 2 The concentration ranges used in this study are summarised in Table 4 . A 100 190 mg.cm -3 aqueous stock solution of ethanol, methanol, ethylene glycol, and 1, propandiolwas prepared and aliquots of the volumes required to generate the 192 required concentrations were spiked into the saliva samples within three hours of 193 the saliva being collected. To account for the lower concentration of the GHB 194 standard, and to maintain a constant saliva background in the GHB 195 characterisation experiments a different approach was adopted. Here 0.9 cm 3 of 196 the saliva was used, and spiked with the required aliquot volume of the 1 mg cm -3 197 GHB methanolic solution, before the volume was made up to 1.8 cm 3 with 198 physiological saline (NaCl(aq) 8.5 g.dm -3 ). The ammonia present in the saliva and the 199 GHB salt co-eluted with methanol and suppressed the formation of methanolic 200 product ions (Ammonia has a higher proton affinity than methanol). This 201 interference was eliminated by the addition of 150 µl of 8 % HCL solution into the 202 saliva samples before the sampling rod was placed into the vial. 203
Once the analytes had been added the saliva standards were homogenised. 204
Immediately this had been done a PDMS coated titanium cartridge was removed 205 from its sealed thermal desorption tube and placed into the vial, which was then 206 sealed immediately. It was important that this procedure was undertaken in a fast 207 and reproducible manner to minimise the effects of evaporative losses in the study. 208
The sealed vial was then placed into a heating-block, maintained at 37 °C for 10 209 minutes. At the end of the extraction-time the vial was uncapped and the PDMS 210 coated titanium cartridge was removed with stainless steel tweezers and excess 211 fluid removed by gently wiping it with a lint-free wipe ('Kimcare' Kimberly-Clark 212
Professional, UK). The PDMS coated titanium cartridge was then placed 213 immediately into its glass thermal desorption tube and analysed. Cross-214 contamination checks were run by taking blank runs between every measurement. 215
Results and discussion 216
Evaluation of responses 217 Figure 2 shows the GC-DMS response surfaces from methanol (A), ethanol (B), 218 ethylene glycol (C), 1,3-propandiol(D) and GHB (E) at three levels of column-loading 219 that span the ranges of analyte concentrations associated with the physiological 220 thresholds of these compounds. The four dispersion-field levels used (Table 3 ) 221 enabled analytical responses to be resolved 222 The lowest column loading applied generated a low intensity split peak that 259 straddled -337.4 V.cm -1. At the same dispersion-field (22 kV.cm -1 ) 1, propandiolyielded two features, both resolved from the reactant ion peak. The peak 261 at a compensation-field of 15.4 V.cm -1 was attributed to a proton bound dimer ion 262 cluster. The feature attributed to a hydrated monomer-ion cluster was observed to 263 shift to more negative compensation-fields with increasing column-loading. At 80 ng 264 the peak maximum was at a compensation-field of -283.4 V.cm -1 , shifting to -261.2 265 V.cm -1 when the column-loading was reduced to 2.7 ng. 266 GHB also showed complex behaviour with a dispersion-field of 23kV.cm -1 . In 267 addition to well-resolved hydrated protonated monomer cluster ions and proton-268 bound dimer cluster ions, fragment ions obscured within the RIP envelope were also 269 evident, and the compensation-field maxima of these fragment ions shifted with 270 increasing column-loading of GHB. Hydrated protonated monomer cluster ions had 271 a compensation field peak maximum at -131.8 V.cm -1 and the proton-bound dimer 272 compensation-field maxima was observed at 33.2 V.cm -1 . No discernible trend in a 273 shift in compensation-field maxima was observed with column loading for the 274 hydrated protonated monomer cluster ion, and the proton-bound dimer was not 275 formed at the lowest column loading of 0.51 ng. At a column loading of 12.9 ng two 276 unresolved fragment ions were discernible within the RIP envelope. The most 277 intense feature was at 310.2 V.cm -1 with a shoulder at -296.8 V.cm -1 . Reducing the 278 column loading to 1.9 ng resulted in a single fragment ion with a compensation-field 279 peak maximum at -301.2 V.cm -1 and at a column loading of 0.51 ng the fragment 280 ion was still observable with a compensation-field peak maximum of -288 V.cm -1 . 281
Despite the complexity of the responses it was possible to generate well resolved 282 and analytically useful chromatographic peaks, see Figure 5 . The chromatograms 283 for ethylene glycol, 1,3-propandiol and GHB were generated by integration of the 284 differential mobility spectra across the proton-bound dimer ion features and the 285 hydrated protonated monomer responses, and these are shown as discrete traces 286 in Figure 5 overlaid with the summed chromatographic response. For ethanol and 287 methanol the chromatograms were generated by integration of the complicated 288 features that contained hydrated protonated monomers and proton-bound dimer 289 ions. Figure 5 shows the intensities of the peaks reflecting the differences in the 290 ionisation efficiencies as well as the column-loadings of the five compounds. Of 291 particular note was the behaviour of ethylene glycol with a peak shape that 292 indicated a saturated response with significantly lower sensitivity compared to the 293 other four compounds. 294
Calibration 295
Calibration of the differential mobility spectrometer was based on the peak volumes 296 for the proton-bound dimer ion responses for the two glycols and GHB. The ethanol 297 calibration was based on the integration of the complicated feature containing 298 unresolved hydrated protonated monomers ion clusters and proton-bound dimer 299 ions while the methanol calibration peak volume was taken from the proton-bound 300 monomer ion response. Table 4 summarises the calibration parameters data. 301
Saliva analysis 302
The responses obtained from saliva spiked with a range of concentrations of the 303 analytes are summarised in Figure 6 found to be more sensitive and more reproducible than adopting a passive drool 318 approach. Further, obtaining a passive drool sample requires significantly more 319 patient / participant training and compliance than placing a small rod under their 320 tongue and as such is likely to be a more practical approach to working with 321 patients/participants who may have analytes at levels high enough to be a cause of 322 concern for their safety and welfare [13] . Nevertheless the adoption of a passive 323 drooled-saliva approach enabled a matrix that approximated the intended sampling 324 conditions to be acquired safely and practicably. Finally, the loss of the more 325 volatile methanol and ethanol to the saliva headspace and hence from the 326 experiment also needs to be acknowledged as a methodological weakeness. 327
The fragmentation behaviour observed during the method development stage with 328 liquid injections was not observed in the saliva studies. The presence of other 329 closely eluting components within the chromatogram made background subtraction 330 problematic and subsequently it was not possible to investigate fragment ion 331 artefacts with confidence. The on-column masses of methanol recovered were 332 estimated to fall in the range 0.35 ng to 3 ng over the range 100 mg.dm -3 to 2 g.dm -333 3, and similarly for ethanol the on-column masses were estimated to fall in the range 334 29 ng to 42ng. Recoveries for ethylene glycol fell were lower with up to 7 ng 335 obtained at high saliva loadings of 3 g.dm -3 , contrasted with 1,3-propandiol 336 recoveries of up to 22 ng at the same level. GHB was the most efficiently recovered 337 from saliva with 10 ng recovered at 100 mg.dm -3 increasing to an estimated on-338 column mass of 34 ng at 400 mg.dm -3 . 339
Conclusion. 340
This pilot study demonstrates the effective recovery, detection and semi-341 quantitative estimation of all the analytes of interest to this work. This represents a 342 potentially useful methodological advance in the rapid assessment of alcohol 343 toxicity and embodied within a TD-GC-DMS or a TD-GC-IMS for it provides a fieldable 344 approach for a rapid screen and evaluation protocol for alcohols present at toxic 345 levels from a single non-invasive sample. This has not been possible previously and 346 has the potential for the development of point-of-care toxicity assessment in 347 emergency room settings. Indeed this study, in concert with others, is developing 348 the concept of extending volatile biomarker measurement from breath to a range of 349 excretory routes. There are instances when breath sampling might be problematic 350 (a propensity for an inebriated patient to vomit for instance) and as such skin and 351 saliva offer alternative routes and techniques for studying and exploiting the 352 tissue/blood/breath-skin-saliva excretion mechanics for non-invasive diagnostics 353 [17] . 354
The apparently simplicity of the analytes belies significant complexity in the ion 355 chemistries associated with their detection using ambient ionisation or radioactive 356 ionisation approaches. Earlier mass spectrometric studies with alcohols have 357 identified the formation of fragment ions associated with proton transfer ionisation 358 approaches [18, 19 and 20] . The presence of signals due to product ion 359 fragmentation would not appear to be without precedent. The alcohol product ions, 360
and their fragment ions, are highly mobile and therefore are associated closely with 361 the water-based reactant ion signals. Increasing resolution between the reactant 362 ion signal and analyte signals by increasing the dispersion field strength has the 363 combined effect of reducing the analytical sensitivity by reducing the analytical area 364 of the ion filter while at the same time promoting fragmentation reactions [21 365 and 22] . The possible ion fragmentation of GHB has not been reported previously. 366
Compensation field maximum shifts attributable to the auto-modification of the 367 transport gas by analyte neutrals was also observed and this is an area that will 368 require further investigation to characterise it completely. 369
The study of fragmentation mechanisms, products and their ramifications for 370 alcohol determination by differential mobility spectrometry along with the 371 development of detection and signal processing algorithms to enable peak-shift 372 from auto-modification of the differential mobility transport gas to be handled 373 efficiently are logical next steps in the development of this area. In parallel to such a 374 study will be the refinement of the methodology to reduce the chromatographic run 375 time to less than 300 s, and the continued development of the sampling approach 376 to reduce the sampling time so that a total analytical run time of 600s might be 377 achieved. This would to enable the delivery of a clinical pilot study within an 378 appropriate poisons unit to assess the efficacy of this approach in patients, 379 benchmarked to current gold-standard toxicity screens. (1) Obtained as a methanolic solution of concentration 1 mg.cm -3 in CH3OH. Note. E d is the dispersion field (Some instruments use the term Radiofrequency Voltage.); T is the gas temperature within the ion filter, sometimes referred to as "cell" temperature; N is the number of steps in the differential mobility compensation field scan (defining the fidelity of the spectral features); and, δt is the dwell time for each step in the compensation field scan (defining the sensitivity of the response). The combination of N and δt defines the chromatographic performance of the system.
The heating and cooling rates of the DMS cell were too slow to enable multiple levels to be selected within a single chromatographic run. Further, switching the number of steps and step duration in the DMS spectra during a chromatographic run was not possible. Consequently mid-range levels were used. Note: these ranges relate to the linear portion of the calibration range where the integrated peak volume (I) was given by: Figure 7 
